Physician Assistant Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Tegan Presley

Physician Assistant Saint Paul, MN Physician Assistant

NPI 1669883757 CMS profile 11209877

1026 7Th St W, Saint Paul, MN 55102

Open in the dashboard

General payments

$6,731

30 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tegan Presley of Saint Paul, MN is reported in the CMS Open Payments database as having received $6,731 across 30 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,664 26
2024 General $31 2
2023 General $20 1
2022 General $16 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tegan Presley
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Tegan Presley were reported at $6,664. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Tegan Presley Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $16 $155 $48–$522 $149
2023 $20 $167 $52–$557 $160
2024 $31 $178 $55–$600 $164
2025 $6,664 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Indivior Inc. $6,551 20 payments
  2. Novo Nordisk Inc $46 2 payments
  3. Dexcom, Inc. $37 2 payments
  4. Pfizer Inc. $36 2 payments
  5. GlaxoSmithKline, LLC. $30 2 payments
  6. Abbott Laboratories $18 1 payment
  7. Sanofi Pasteur Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,401 2 payments
  2. Travel and Lodging $2,555 11 payments
  3. Food and Beverage $743 16 payments
  4. Education $32 1 payment
Products named General payments · program years 2022–2025
  1. SUBLOCADE $6,551 20 payments
  2. Dexcom G6 Transmitter $37 2 payments
  3. PREVNAR 20 $36 2 payments
  4. COMIRNATY $36 2 payments
  5. BEXSERO $30 2 payments
  6. ABRYSVO $20 1 payment
  7. FreeStyle Libre 3 $18 1 payment
  8. TRUMENBA $16 1 payment
  9. PAXLOVID $16 1 payment
  10. PEDIARIX $15 1 payment
  11. Other $72 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 52 drugs

Part D claims

1,266

Median for Physician Assistant: 241

Drug cost

$75,563

Median for Physician Assistant: $4,110

Branded share of claims

22.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ozempic Semaglutide Brand 26 $42,149
Januvia Sitagliptin Phosphate Brand 11 $9,750
Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl Brand 78 $6,023
Atorvastatin Calcium Generic 103 $1,167
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 41 $1,140
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 25 $1,082
Ventolin Hfa Albuterol Sulfate Brand 17 $941
Duloxetine Hcl Generic 15 $822
Hydroxyzine Hcl Generic 37 $649
Albuterol Sulfate Hfa Albuterol Sulfate Brand 15 $612

The 10 drugs with the highest cost, of 52 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$1,989

Of which drugs: $212

Medicare patients

33

Average age 57

Services billed

129

19 women, 14 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 39%
High blood pressure 36%
Arthritis 36%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Sarscv2 vac 30mcg trs-suc im 91320 Office 11 13 $187

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

30 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record